Scope of the Circular
- The Circular applies specifically to all entities within the medical device industry.
- It covers all variations, amendments, or changes made to the CPR issued by the Center for Device Regulation, Radiation Health, and Research (CDRRHR).
Procedures for Filing Variation Applications
- The application for variation of medical device product registration follows guidelines in FDA Circular No. 2016-010 but introduces new procedures under CDRRHR's Licensing and Registration Division.
- Only one variation application per transaction is permitted irrespective of the number of CPRs held by the applicant.
- Acceptable variations include:
- Change of legal manufacturer, exporter, and manufacturer if the name and address remain consistent across all CPRs.
- Change of importer and distributor.
- Change of location/address of importer and distributor.
- Change of manufacturer’s address.
- Change or addition of sterilization sites.
- Change of label design.
- Change of Instruction for Use (IFU).
- Other changes uniform across all CPRs.
- Fees and charges are computed based on the number of CPRs affected by the amendment.
- The applicant must submit a comprehensive list of all CPRs to be amended in both PDF and Word formats, including exact product descriptions and registration numbers.
- Notification of approval of changes will be provided via letter.
- These procedures apply to all variation applications received from July 22, 2016, onward.
Post-Approval and Re-Issuance
- All approved changes will be incorporated into the CPR during the product registration renewal.
- Companies may request re-issuance of the CPR to reflect changes immediately, subject to payment of a re-issuance fee.
Repealing Clause
- Any prior issuances conflicting with this Circular are repealed, rescinded, or modified accordingly.
Separability Clause
- If any provision or its application is declared invalid, the rest of the Circular’s provisions will remain effective and enforceable.
Effectivity
- The Circular becomes effective fifteen (15) days after approval, ensuring timely implementation of the new procedures.